Who is the new President at Nomad Power Solutions, Inc?

Nomad Power Solutions, Inc. named Bas van der Baan President, announced September 26, 2023.

Which similar companies made leadership changes around the same time?

Scale Microgrids (September 19, 2023), CH4 (November 8, 2023), AnHeart Therapeutics (September 28, 2023) and Global Bioenergies (October 19, 2023) also announced leadership changes within 45 days of Nomad Power Solutions, Inc.

LIXTE Appoints Bas Van Der Baan as President and Chief

PUBLIC · NMADSep 26, 2023

Position

President

Company

Nomad Power Solutions, Inc.

Bas van der Baan

v.der-baan@lixtec.com

Boca RatonInformation TechnologyBiotechnologyEnergyOil And GasHealth CareScience And EngineeringRenewable EnergySolarTherapeuticsEnergy ManagementEnergy Efficiency

Description

Founder John S . Kovach Named Executive Chairman PASADENA, CA, Sept. 26, 2023 -- LIXTE Biotechnology Holdings, Inc

Quick answer

LIXTE Appoints Bas Van Der Baan as President and Chief (September 26, 2023). Nomad Power Solutions, Inc. is based in Boca Raton, Florida, United States.

Who is the new President at Nomad Power Solutions, Inc?: Nomad Power Solutions, Inc. named Bas van der Baan President, announced September 26, 2023.
What did Nomad Power Solutions, Inc. announce on September 26, 2023?: Founder John S . Kovach Named Executive Chairman PASADENA, CA, Sept. 26, 2023 -- LIXTE Biotechnology Holdings, Inc
What does Nomad Power Solutions, Inc. do?: LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies.
Where is Nomad Power Solutions, Inc. based?: Nomad Power Solutions, Inc. is based in Boca Raton, Florida, United States.
Which similar companies made leadership changes around the same time?: Scale Microgrids (September 19, 2023), CH4 (November 8, 2023), AnHeart Therapeutics (September 28, 2023) and Global Bioenergies (October 19, 2023) also announced leadership changes within 45 days of Nomad Power Solutions, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Energy and Oil And Gas

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Scale Microgrids Welcomes Neil Maguire as Chief Technology Officer - Latest Digital Transformation Trends (September 19, 2023)
CH4 Global Appoints Strategic Chief Financial Officer to Propel Profitable Growth and Global Expansion (November 8, 2023)
AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer (September 28, 2023)
Global Bioenergies announces the appointment of Martin Stephan as Chief Business Officer - Benzinga (October 19, 2023)
Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization (September 26, 2023)
MATI THERAPEUTICS ANNOUNCES PROMOTION OF CHRIS MULLER TO CHIEF OPERATING OFFICER (September 26, 2023)

Who to call at Nomad Power Solutions, Inc., and when

A new leader at Nomad Power Solutions, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day Nomad Power Solutions, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nomad Power Solutions, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nomad Power Solutions, Inc.. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nomad Power Solutions, Inc.

Location

433 Plaza Real

Boca Raton, Florida, United States

About

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. Major drivers of cancer are defects in the switches that turn the biochemical pathways in cells on or off. Most cancer research over the past 30 years has focused on the "on" switches because the "off" switches, especially the master "off" switch protein phosphatase (PP2A), were believed to cause intolerable toxicity in patients. LIXTE has achieved a breakthrough with its novel, first-in-class lead clinical compound and PP2A inhibitor, LB-100, demonstrating that LB-100 is readily tolerated in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data (see www.lixte.com), LB-100 has the potential to significantly improve outcomes for patients undergoing various chemotherapies or immunotherapies. LIXTE's new approach has no known competitors and is covered by a comprehensive patent portfolio. Initial proof-of-concept clinical trials are in progress.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nomad Power Solutions, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans